BIOMAT Database Logo BIOMAT Database Logo

Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. 1987

E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Center for Interdisciplinary Research in Immunology and Disease, UCLA 90024.

The capacity of human immunodeficiency virus (HIV) antibody-positive sera from homosexually active men without acquired immune deficiency syndrome to lyse the HIV-infected T cell lines MOLT-4f and CCRF-CEM (CEM) in cooperation with lymphocytes from normal donors was investigated. Twenty-seven HIV antibody-positive sera, most of which enhanced the killing of HIV-infected MOLT-4f and CEM target cells by normal mononuclear cells were studied in detail. HIV antibody-positive sera resulted in lysis at dilutions as high as 1/10,000. HIV antibody-negative sera did not augment lysis of infected target cells. In addition, lysis of uninfected targets was not enhanced in the presence of HIV antibody-positive sera. Because fractionation of the HIV antibody-positive sera on a protein A affinity column resulted in recovery of the activity from the IgG fraction, the extra cytotoxic activity mediated by nonimmune cells in the presence of immune sera appears to be antibody-dependent. Furthermore, the cytotoxic effector cells were in the nonrosetting fraction of lymphocytes and expressed Leu-11 (cluster designation (CD)15) antigens, which is characteristic of cells participating in antibody-dependent cellular cytotoxicity reactions. The antibody specificity of the sera, determined by radioimmunoprecipitation, provides evidence that antibody-dependent cellular cytotoxicity can occur even when there are no detectable antibodies directed against gag proteins. Sera which lacked detectable antibodies to the envelope protein gp120 by radioimmunoprecipitation did not mediate antibody-dependent cellular cytotoxicity.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D012191 Retroviridae Proteins Proteins from the family Retroviridae. The most frequently encountered member of this family is the Rous sarcoma virus protein. Leukovirus Proteins,Retrovirus Proteins,Proteins, Leukovirus,Proteins, Retroviridae,Proteins, Retrovirus

Related Publications

E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
August 1993, Virology,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
HLA restriction of cell-mediated lysis of influenza virus-infected human cells.
December 1977, Nature,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
July 1998, Cancer research,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
April 1975, European journal of immunology,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Hybrid antibody-mediated lysis of virus-infected cells.
April 1987, European journal of immunology,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.
January 1999, Molecular membrane biology,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.
December 1987, The Journal of infectious diseases,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Antibodies to granulocytes in patients infected with human immunodeficiency virus.
June 1992, The Journal of laboratory and clinical medicine,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Measles antibodies in human immunodeficiency virus-infected adults.
March 1992, The Journal of infectious diseases,
E A Ojo-Amaize, and P Nishanian, and D E Keith, and R L Houghton, and D F Heitjan, and J L Fahey, and J V Giorgi
Antibody mediated complement dependent lysis of virus infected cells.
January 1979, Springer seminars in immunopathology,
Copied contents to your clipboard!